This Review summarizes recent advances in bio-inspired adaptive nanoparticles for cancer applications and discusses the major challenges and future directions for developing next-generation adaptive nanomedicines with translational potential.
Abstract
Living systems, including cells and viruses, exhibit intrinsic adaptivity that enables them to navigate complex biological environments through dynamic regulation of their structural and functional states. Inspired by these natural processes, bio-inspired adaptive nanoparticles have emerged as a promising strategy to overcome the limitations of static nanocarriers. These engineered systems sense or recognize changes in the local microenvironment and subsequently undergo spatiotemporal remodeling of their structures, biointerfaces, or biological functions, thereby meeting stage-specific requirements for cancer delivery and therapy. In this Review, we summarize recent advances in bio-inspired adaptive nanoparticles for cancer applications. We first outline representative natural adaptive particles and their underlying adaptive mechanisms. We then discuss how these principles guide the design of structurally and functionally adaptive nanoparticles to overcome tumor-delivery barriers and regulate the tumor microenvironment. Finally, we highlight approaches for the mechanistic and quantitative validation of adaptive behavior and discuss the major challenges and future directions for developing next-generation adaptive nanomedicines with translational potential.
Cancer remains a major global health challenge, and nanoparticle-based drug delivery systems have emerged as a promising strategy for targeted cancer therapy. However, clinical translation is still limited by an incomplete understanding of how nanoparticles navigate the tumor microenvironment (TME) throughout the deliv...
Meng-Xin Ban, Si-Fang Zhao, Zi-Yu Liu et al.· Pharmaceutics· 0 citations
This review examines the main classes of nanoplatforms currently explored for cancer therapy, including inorganic, polymeric, lipid-based, and hybrid organic–inorganic systems, and considers emerging directions in AI-guided nanoparticle engineerization design and natural-compound-based nanomedicines, both of which are...
C. Boncristiani, F. Baldassarre, Khadija Eddahaoui et al.· Materials· 0 citations
Nanomedicine harnesses the unique benefits of nanocarriers to markedly enhance drugs targeting tumors, which is becoming a promising approach to achieve precise and effective antitumor therapy. Extracellular vesicles (EVs), natural nanoscale entities, have garnered extensive attention due to their high biocompatibility...
Xuan-Han Zhang, Xiao-Wei Zhou, S. Fu et al.· Pharmaceutics· 0 citations
Novel NCs like microemulsions, vesicular (liposomes), and nanoparticular NCs are created and explored, which have unique improved penetration and retention in the tumour tissue.
Shalu Tiwari, Abhijeet Ojha, A. Singh et al.· Journal of Drug Delivery and...· 0 citations
A persistent challenge in nanomedicine is achieving functional delivery of therapeutic molecules across physiological barriers. Organs impose distinct transport constraints, including the blood–brain barrier, renal filtration, hepatic sequestration, and pulmonary clearance. Although substantial effort has focused on en...
Zi-Cheng Deng, A. Dunn, Daniel Q. Sun et al.· Applied Physics Reviews· 0 citations
Conventional anticancer nano-therapies often rely on passive accumulation through the enhanced permeability and retention (EPR) effect, resulting in insufficient penetration of tumor tissue and heterogeneous cellular uptake. Smart nanocarriers that are able to respond to specific stimuli through conformational, charge-...
Di-Pu Pan, Shubhajit Sarkar, Souvik Adhikary et al.· Journal of Drug Delivery and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.